tiprankstipranks
Nuo Therapeutics (AURX)
OTHER OTC:AURX
US Market

Nuo Therapeutics (AURX) Financial Statements

10 Followers

Nuo Therapeutics Financial Overview

Nuo Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.07; its P/E ratio is -5.22; Nuo Therapeutics is scheduled to report earnings on August 8, 2022, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 197.01K$ 232.24K$ 118.17K$ 61.10K$ 74.00K
Gross Profit$ 407.83K$ 178.42K$ 97.68K$ 50.68K$ 61.28K
EBIT$ -653.15K$ -790.64K$ -871.89K$ -855.75K$ -958.66K
EBITDA$ -626.16K$ -764.25K$ -845.87K$ -829.91K$ -934.61K
Net Income Common Stockholders$ -653.15K$ -790.64K$ -871.89K$ -855.75K$ -959.52K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 928.68K$ 582.59K$ 399.37K$ 1.31M$ 2.05M
Total Assets$ 1.88M$ 1.60M$ 1.39M$ 2.22M$ 3.05M
Total Debt$ 255.59K$ 276.20K$ 296.31K$ 315.92K$ 335.05K
Net Debt$ -673.09K$ -306.39K$ -103.06K$ -989.34K$ -1.72M
Total Liabilities$ 838.73K$ 873.18K$ 914.44K$ 882.79K$ 856.02K
Stockholders Equity$ 1.04M$ 726.72K$ 470.83K$ 1.34M$ 2.19M
Cash Flow-
Free Cash Flow$ -671.41K$ -796.78K$ -905.89K$ 2.11M$ -826.34K
Operating Cash Flow$ -671.41K$ -794.88K$ -905.89K$ 2.11M$ -821.69K
Investing Cash Flow-$ -1.90K-$ -5.34K$ -4.65K
Financing Cash Flow$ 962.50K$ 1.03M--$ 0.00
Currency in USD

Nuo Therapeutics Earnings and Revenue History

Nuo Therapeutics Debt to Assets

Nuo Therapeutics Cash Flow

Nuo Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis